A B S T R A C T To investigate whether skeletal muscle is resistant to insulin in insulinopenic states, insulin binding and biological effects on glucose utilization were studied in isolated soleus muscles from 24-or 48-h-fasted mice and from streptozotocin-diabetic mice. Both 48-h fasting and diabetes led to an increase in insulin binding at insulin concentrations <3.4 nM. In both states, submaximal concentrations of insulin were also more effective in stimulating muscle 2-deoxyglucose uptake and glycogen synthesis, and in activating glycogen synthase. This resulted in a two-to fourfold leftward shift in the insulin dose-response curves in muscles from both groups compared with control. No change in insulin binding or biological effects was detected in muscles from 24-h-fasted mice. Maximal insulin effectiveness on 2-deoxyglucose uptake and glycolysis was either unchanged or only slightly enhanced in 48-h-fasted mice and in diabetic animals, compared with controls. Maximal insulin effects on glycogen synthesis and glycogen synthase activation were unaltered by fasting or diabetes. Basal glucose uptake and glycolysis were similar in all groups of mice. In conclusion, when soleus muscles from 48-hfasted mice and from diabetic mice are compared with controls it can be observed that, (a) at low insulin concentrations insulin binding is increased and insulin effectiveness in stimulating glucose transport and metabolism is enhanced; (b) biological responses to maximally effective insulin concentrations are either unaltered or slightly increased; (c) basal rates of glucose transport and metabolism are essentially unaltered. These results indicate that in insulinopenic states soleus muscle is not insulin resistant in vitro but is hyper-INTRODUCTION Fasting and insulinopenic diabetes are characterized by insulinopenia and altered glucose metabolism. In adipocytes, it has been demonstrated that fasting and streptozotocin diabetes are accompanied by an increase in insulin binding associated with a profound decrease of basal and insulin-stimulated glucose metabolism (1) (2) (3) (4) (5) (6) . In muscle, insulinopenic diabetes and starvation have been reported to lead to a decreased glucose transport and responsiveness to insulin (7) (8) (9) . The latter studies, however, involved the heart and the diaphragm which are highly specialized, constantly contracting muscles, not representative of the skeletal muscle mass. Other studies, performed in the perfused hindquarter from starved or ketoacidotic diabetic rats (10) (11) (12) , have indeed suggested that important differences exist between heart and skeletal muscle in the regulation of glucose metabolism.
In contrast to the many reports dealing with adipocytes (1) (2) (3) (4) (5) (6) , there is to our knowledge no available study concerning insulin binding and action in skeletal muscle in insulinopenic states. Yet, skeletal muscle is a major site of insulin action and glucose utilization. We have recently shown that it is possible to measure both insulin binding and biological effects in the isolated mouse soleus (13, 14) , a slow-twitch red skeletal muscle. The present experiments have been undertaken to investigate whether the intrinsic function of the soleus with regard to insulin binding and action on glucose metabolism is altered in insulinopenic states such as fasting and streptozotocin diabetes in mice. METHODS Animals. 7-to 8-wk-old Swtiss albino mice were used throughout this study. Unless otherwise indicated, they were tion, Inc. * 0021-9738/79/11/1505/11 $1.00 fed ad lib. with UAR laboratory chow (Villemoisson, Epinay/ Orge, France), containing 21% protein, 4% fat, and 51% carbohydrate until the time of sacrifice (9-11 a.m.). Mice were maintained in a constant temperature (23°C) animal room, with a fixed 12-h artificial light cycle. In fasting experiments, mice were deprived of food but had free access to water. Diabetes was induced by an intraperitoneal injection of streptozotocin (200 mg/kg body wt) following a 6-h fast; animals were then allowed free access to food and water, and were studied 10 d after injection. Mice were checked for hyperglycemia 72 h before sacrifice: under light ether anesthesia a blood sample (50 ILI) was withdrawn from the retroorbital sinus, centrifuged at 40C, and the plasma used for glucose determination (15) .
Soleus muscle isolation. Mice were killed by cervical dislocation and soleus muscles were isolated as previously described (16) . Muscles were removed from the leg, attached to a stainless steel holder, and suspended individually in flat-bottomed glass tubes. Each muscle was immersed in 1.5 ml of Krebs-Ringer bicarbonate buffer (pH 7.35) containing 20 mg/ml defatted bovine albumin (KRB-BSA)' (17) and the additions specified for each experiment. The tubes were sealed with rubber stoppers and gassed with O2:CO2 (95:5, vol:vol) during the preincubation period and the first 10 min of the incubation. Muscles were always preincubated for an initial 15-min period and then incubated using the following procedure.
Insulin binding studies. Muscles were incubated for 4 h at 20°C in 1.5 ml of the KRB-BSA buffer, supplemented with 2 mM pyruvate and containing "251-insulin (specific activity 200-240 ,uCi/4ig, i.e., 1,200-1,400 Ci/mmol) at 0.8-1 ng/ml (i.e., 0.13-0.17 nM) and varying concentrations of unlabeled insulin (13) . Some muscles were incubated with unlabeled insulin at 50 ,ug/ml (i.e., -8,000 nM) to measure nonspecific binding (13) . After 4 h, when a steady state of insulin binding (13) was achieved, muscles were washed six times with 3 ml of chilled isotonic NaCl containing 2.5 mg/ml ofhuman serum albumin, each washing step consisting of a 5-min incubation period.2 After washing, muscles were dissolved in 0.3 ml of 1 N NaOH and counted for 125I radioactivity.
Deoxyglucose uptake studies. Deoxyglucose uptake was measured at 20°or 37°C. At 20°C, 2-deoxy-D-[1-'4C]glucose (0.5 mM, 1 ,uCi/1.5 ml) was added to the incubation medium at the end of the 4-h incubation period described above, and the incubation was continued for 15 min. When uptake was measured at 37°C, 2-deoxy-D-[1-_4C]glucose (0.1-10 mM, 0.2 ,uCi/1.5 ml) was added for 10 min at the end of a 30-min incubation period with or without insulin. Initial rates of uptake were measured under these conditions of temperature and incubation duration (not shown). After washing as described above, muscles were dissolved in 0.3 ml of 1 N NaOH and counted for 14C radioactivity.
Glucose metabolism studies. Glucose (14) .
in the presence of D-[5-3Hlglucose (5 mM, 1 ,uCi/1.5 ml). At the end of the incubation, 3H2O in the medium and labeled glycogen in muscles were measured as described previously (16) .
Glycogen synthase activation studies. For measurement of glycogen synthase activity, muscles were preincubated for 90 min at 37°C in the KRB-BSA buffer supplemented with 2 mM pyruvate, and incubated for 30 min in the same medium containing varying concentrations of insulin. At the end of the incubation, muscles were freeze-clamped in liquid nitrogen, powdered with a pestle precooled in liquid nitrogen, and briefly sonicated (Alcatel Sonifier, Paris, France) at 0°C in 0.5 ml ofcold buffer (50 mM Tris-buffer, pH 8.2,5 mM EDTA, 100 mM potassium fluoride) to achieve homogenization. After centrifugation of homogenates at 10,000 g for 5 min at 4°C, supemates were collected and assayed immediately.
Glycogen synthase activity was assayed essentially as described by Thomas et al. (19) . Samples (30 ,ul) Glycogen content was measured in muscles as described elsewhere (20) .
Plasma determinations. Mice were anesthetized with sodium pentobarbital (100 mg/kg body wt i.p.) and a blood sample was withdrawn from the inferior vena cava, using a heparinized syringe. Blood samples were centrifuged at 40C and the plasma was used for determination of glucose by the glucose oxidase method (15) and immunoreactive insulin (21) with mouse insulin used as standard.
Calculations and statistics. An aliquot sample of alkaline muscle solution was kept for protein determination of each individual muscle preparation, human serum albumin being used as standard (22 (Fig.  1) . The binding of 1251-insulin and its inhibition by unlabeled insulin were similar in control and in 24-hfasted mice (Fig. 1A) . In contrast 48-h fasting (Fig. 1B) and diabetes (Fig. 1C) Insulin effect on 2-deoxyglucose uptake in muscles of control, fasted, and streptozotocin-diabetic mice. The uptake of 2-deoxyglucose by muscles was used as an index of glucose transport and phosphorylation. As shown in Fig. 3A , muscles from 48-h-fasted mice accumulated significantly more 2-deoxyglucose at all insulin levels than did muscles from controls; the basal value of 2-deoxyglucose uptake (in the absence of insulin) was similar in control and 48-h-fasted mice. After a 24-h-fast, 2-deoxyglucose uptake was not significantly different from that observed in controls, in the absence as well as in the presence of submaximal and maximal concentrations of insulin (not shown). In diabetic mice the uptake of 2-deoxyglucose was also increased compared with controls ( Fig. 3B ) but only at submaximal concentrations of the hormone. When the results were expressed as percent of maximal insulin effect (Fig. 3C) , the dose-response curves in muscles from 48-h-fasted and from streptozotocin-diabetic mice were shifted to the left by a factor of 2-3, compared with that obtained in muscles from control mice. This is in agreement with the observation that at submaximally stimulating concentrations ofinsulin (i.e., <3 nM), higher amounts of binding were achieved with the same concentrations of hormone in 48-h-fasted and in diabetic mice than in controls (Table II) .
Basal and maximally insulin-stimulated 2-deoxyglucose uptake was measured at increasing concentrations of 2-deoxyglucose in muscles of control and 48-h-fasted mice. Uptake was similar in both groups of mice over the range of sugar concentrations tested (Fig. 4) . The shape ofthe curves suggests two components: a saturable component observed at 2-deoxyglucose concentration <2-5 mM, and a nonsaturable linear component at higher concentrations. Neither component was altered by fasting (Fig. 4) . Table III also shows that phloridzin, an inhibitor of carrier-mediated glucose transport (25) , prevented basal and insulin-stimulated sugar uptake to a similar extent in muscles from control and 48-hfasted mice.
Insulin effect on glycolysis in muscles of control, fasted, and streptozotocin-diabetic mice. To investigate the effect of insulin on more distal steps of glucose metabolism, glycolysis and glycogen synthesis were measured in muscles from control, fasted, or streptozotocin-diabetic mice. As shown in Fig. 5A 
Muscles were incubated as described in Fig. 1 (submaximal and maximal). No difference was observed for insulin-stimulated glycolysis between muscles from controls and streptozotocin-diabetic mice (Fig. 5C ). The basal rates of glycolysis were similar in all groups of mice. Insulin effect on glycogen synthesis and glycogen synthase activation in muscles of control, fasted, and streptozotocin-diabetic mice. The effect of insulin on glycogen synthesis from [5-3H] glucose is shown in Fig.  6 . Insulin stimulated glycogen synthesis to a similar extent in muscles from controls and 24-h-fasted mice (Fig. 6A) . Submaximal concentrations of insulin were more effective in muscles from 48-h-fasted and diabetic mice than in muscles from controls ( Fig. 6B and C) ; with higher insulin concentrations, glycogen synthesis was not significantly different in muscles from 48-hfasted or diabetic mice compared with controls. The greater sensitivity of muscles from 48-h-fasted or diabetic mice to submaximally stimulating concentrations of insulin was more apparent when the results were expressed as a percentage of maximal insulin effect ( Fig. 7) : thus, half-maximal insulin effect was observed at 0.90±0.07 nM (six experiments) for controls; 0.46±0.07 nM (four experiments) for 48-h-fasted mice; 0.40 and 0.62 nM (two experiments) for streptozotocin-diabetic mice. Basal glycogen synthesis (measured in the absence of insulin) was significantly lower in muscles from diabetic mice compared with controls (Fig. 6C) .
The stimulation of glycogen synthesis by insulin could result from an increase in glucose transport and/or from an activation of glycogen synthase. It has been suggested (26) that activation of glycogen synthase by insulin in skeletal muscle occurs via a mechanism independent of the hormone's effect on glucose trans- Fig. 8A and B) . Thus, a halfmaximal effective concentration was -2 nM for controls and 0.5 nM for 48-h-fasted and streptozotocin-diabetic mice. Fasting and diabetes did not affect either the basal percentage of active (I) form of glycogen synthase or the extent ofenzyme activation by insulin (Table IV) . Total enzyme activity was slightly decreased in muscles from 48-h-fasted mice, and unaltered in muscles from diabetic animals. DISCUSSION In these studies we have investigated the consequences of two insulinopenic states, fasting and streptozotocin diabetes, on insulin binding and effects on glucose Deoxyglucose uptake was measured during a 10-min incubation after a 30-min preincubation with or without insulin (33 nM), and with or without phloridzin (5 mM), as described in Fig. 3 . Each value is the mean±SEM of five muscles.
Differences between 48-h-fasted and control mice were not significant.
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Y. Le Marchand-Brustel and P. Freychet [INSULIN], nM FIGURE 7 Insulin dose responses (percent of maximal effect) on glycogen synthesis in soleus muscles of control, fasted, and streptozotocin-diabetic mice. Experimental conditions were as described in Fig. 6 . The percent of maximal insulin effect was obtained from data shown in Fig. 6 , using the mode of calculation described in Fig. 3 .
suggesting an increase in receptor affinity rather than a change in receptor number. The observed increase is in agreement with the concept of an inverse relationship between ambient insulin levels and insulin binding (30) (31) (32) , although the exact mechanisms for such changes in receptor affinity and/or number are presently unknown. Although the endogenous insulin level was already markedly decreased after a 24-h fast (Table I) , no change in insulin binding could be detected in muscles at this stage, a finding at variance with the increase in binding reported in the study of adipocytes from 24-h-fasted rats (2). Because soleus muscle has been shown to exhibit spare receptors (13, 14) , the functional consequence of the observed increase in insulin binding should be an increased insulin response at insulin levels that will occupy fewer receptor sites than the number required for a maximal effect, with the increase in insulin binding not affecting per se the maximal response to the hormone (2, 13, 32) . Therefore, if the effector system(s) is (are) intact, the consequence ofan increased insulin binding should be a leftward shift of the insulin dose-response curves. This was indeed found to be the case for 2-deoxyglucose uptake (Fig. 3C ), glycogen synthesis (Fig. 7) , and glycogen synthase activation (Fig. 8B ) in muscles from both 48-h-fasted and streptozotocindiabetic mice. A leftward shift has also been reported for the insulin-stimulated glucose transport in adipocytes from fasted and diabetic rats (2, 3) . Such a shift was not observed in soleus muscle for glycolysis (Fig.  5) Muscles were treated as described in Fig. 8 . At the end of incubation, muscles were freeze-clamped, homogenized, and glycogen synthase activity was measured as described in Methods, in the absence (I form) or in the presence (I + D form) of 7.2 mM glucose-6-phosphate. The two muscles from one mouse were studied as pairs incubated with or without (basal) insulin (33 nM (33) . Another striking feature of the present study is the observation that, at maximally effective doses, insulin elicited in muscles from 48-h-fasted and from streptozotocin-diabetic mice responses were identical to, or even greater than, the responses observed in control mice. Thus soleus muscles from insulinopenic animals have a normal overall capacity of the glucose transport system, of the glycolytic pathway, and of glycogen synthesis. This is in marked contrast to the classic assertion that glucose uptake and utilization are decreased in muscle as a result of fasting and insulinopenic diabetes (34) . However, most studies have been performed in the perfused rat heart or in the isolated diaphragm which are highly specialized, constantly contracting muscles. It has previously been shown that heart and skeletal muscle differ markedly from each other in the regulation of glucose metabolism (10, 35) . For example, the glycogen content increased in heart (35, 36) and decreased in soleus (Table I ) or in hindquarter (11) muscles during fasting or insulinopenic diabetes. Furthermore, as observed in the present study with soleus muscles from 48-h-fasted mice, recent studies in the perfused rat hindquarter (11, 12, 33) have shown that neither glycolysis nor the capacity for glucose transport is inhibited during starvation.
The present study has also provided some information with regard to the regulation of glycogen synthesis in skeletal muscle (Fig. 8, Table IV ). The activation of glycogen synthesis by insulin results from two types of effects: (a) an activation of glucose transport and/or phosphorylation, as measured by the stimulation of 2-deoxyglucose uptake (Fig. 3) , and (b) an activation of glycogen synthase. The results presented in Fig. 8 (where muscles were incubated in the absence of glucose) clearly indicate that insulin directly activates glycogen synthase, independently of its effect on glucose transport and metabolism. This type of regulation, independent of glucose, also occurs in the perfused rat heart (36). However, marked differences are again observed between heart and skeletal muscle. In our studies, insulin markedly activated glycogen synthase in soleus muscles from streptozotocin-diabetic mice, whereas in perfused heart from alloxandiabetic rats glycogen synthase was completely unresponsive to insulin (36) . It can also be observed that basal glycogen synthase active form (Table IV) was similar in muscles from control and insulinopenic animals, a result that differs from the observation of a decreased basal active form of the enzyme in heart or liver from diabetic rats (36) (37) (38) .
Overall insulin resistance has been demonstrated in insulinopenic states in man (39) and in animals (40, 41) . Insulin resistance in vivo may stem from alterations at the target cell level, or changes in circulating levels of hormones and fuels, or both. The results observed in vitro with soleus muscle in the present study are different from those reported with adipocytes during fasting and streptozotocin diabetes (1) (2) (3) (4) (5) (6) . Thus, both basal and insulin-stimulated glucose uptake and utilization in rat adipocytes have been found to be markedly reduced in these two insulinopenic situations. In contrast to the results in adipocytes, basal and insulin-stimulated glucose uptake and metabolism were essentially unaltered in soleus muscles from fasted or diabetic mice. Furthermore, soleus muscles from insulinopenic mice exhibit an increased sensitivity to insulin (i.e., biological responses to submaximal insulin levels are enhanced), possibly the result of increased affinity of the receptor to the hormone. This was also found to be the case with adipocytes from insulinopenic animals (2, 3). In the latter cells, however, multiple defects in effector systems distal to the insulin receptor markedly depress insulin responsiveness (i.e., biological responses to maximally effective insulin levels) and impede the expression of increased insulin sensitivity. In contrast, the integrity of effector Insulin Action in Muscle in Insulinopenic States systems in soleus muscles from insulinopenic mice allows for full responsiveness of the target tissue and permits a clear-cut demonstration of increased insulin sensitivity. It has recently been hypothesized from observations in adipocytes that the level of insulin to which cells are chronically exposed may play a role in the regulation of the capacity of the glucose transport system (42) . Our data do not suggest that this represents a general mechanism operating in all tissues.
In conclusion, these studies have shown that soleus muscles from 48-h-fasted or streptozotocin-diabetic mice are hypersensitive to low concentrations of insulin and normally responsive to maximally effective doses of the hormone. Despite opposed changes in blood glucose in vivo, these two states exhibit remarkably similar patterns of insulin action and glucose utilization in a skeletal muscle studied in vitro. Several points may explain the apparent discrepancy between the present results with soleus muscle in vitro and overall in vivo insulin resistance in insulinopenic states. It is possible that some other skeletal muscles behave differently from the soleus, although the marked similarity between our data and those observed in the perfused rat hindquarter (33) does not favor this possibility. On the other hand, a pattern of altered glucose metabolism has been reported in the rat soleus when incubated with acetoacetate or fatty acids (43, 44) . Thus it is reasonable to assume that in insulinopenic states in vivo increases in substrates such as free fatty acids and ketone bodies (45) will interfere with muscle metabolism. Concomitant increases in circulating levels of hormones (46) that counteract insulin effects, such as glucagon, catecholamines, and glucocorticoids may also contribute to overall insulin resistance. Our results strongly suggest that the state of glucose intolerance and insulin resistance observed in insulinopenic states in vivo is not the consequence of an intrinsic defect of skeletal muscle with regard to insulin-stimulated glucose utilization.
